These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12678252)

  • 1. Consistency testing of diphtheria and tetanus to replace potency testing for lot release.
    Kreeftenberg JG
    Dev Biol (Basel); 2002; 111():291-8. PubMed ID: 12678252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International collaborative studies on potency assays of diphtheria and tetanus toxoids.
    Van Ramshorst JD; Sundaresan TK; Outschoorn AS
    Bull World Health Organ; 1972; 46(2):263-76. PubMed ID: 4537488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use.
    Winsnes R; Hendriksen C; Sesardic D; Akkermans A; Daas A
    Dev Biol Stand; 1999; 101():277-88. PubMed ID: 10566802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency assay of diphtheria and tetanus toxoids some theoretical and practical considerations.
    Lyng J
    Dev Biol Stand; 1986; 64():47-50. PubMed ID: 3792657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation.
    Sesardic D; Winsnes R; Rigsby P; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):69-76. PubMed ID: 14960263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The consistency approach for the quality control of vaccines.
    Hendriksen C; Arciniega JL; Bruckner L; Chevalier M; Coppens E; Descamps J; Duchêne M; Dusek DM; Halder M; Kreeftenberg H; Maes A; Redhead K; Ravetkar SD; Spieser JM; Swam H
    Biologicals; 2008 Jan; 36(1):73-7. PubMed ID: 17892948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European pharmacopoeia.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    J Biol Stand; 1987 Oct; 15(4):353-62. PubMed ID: 3680303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical evaluation of numbers of animals to be used in vaccine potency testing: a practical approach.
    Akkermans AM; Hendriksen CF
    Dev Biol Stand; 1999; 101():255-60. PubMed ID: 10566799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A consideration of some methods by which the cost of potency assays for diphtheria and tetanus vaccines might be reduced.
    Knight PA
    Dev Biol Stand; 1978; 41():67-72. PubMed ID: 753671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.